NO973242D0 - Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti - Google Patents

Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti

Info

Publication number
NO973242D0
NO973242D0 NO973242A NO973242A NO973242D0 NO 973242 D0 NO973242 D0 NO 973242D0 NO 973242 A NO973242 A NO 973242A NO 973242 A NO973242 A NO 973242A NO 973242 D0 NO973242 D0 NO 973242D0
Authority
NO
Norway
Prior art keywords
diphenylchromanes
gynecomastia
idiopathic
prophylaxis
physiological
Prior art date
Application number
NO973242A
Other languages
English (en)
Other versions
NO973242L (no
Inventor
Niels Korsgaard
Michael Shalmi
Birgitte Hjort Guldhammer
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO973242D0 publication Critical patent/NO973242D0/no
Publication of NO973242L publication Critical patent/NO973242L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO973242A 1995-01-13 1997-07-11 Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti NO973242L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK4295 1995-01-13
DK77395 1995-06-30
PCT/DK1996/000012 WO1996021442A1 (en) 1995-01-13 1996-01-10 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of idiopathic or physiologic gynaecomastia

Publications (2)

Publication Number Publication Date
NO973242D0 true NO973242D0 (no) 1997-07-11
NO973242L NO973242L (no) 1997-07-11

Family

ID=26063181

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973242A NO973242L (no) 1995-01-13 1997-07-11 Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti

Country Status (12)

Country Link
US (1) US5919812A (no)
EP (1) EP0809496A1 (no)
JP (1) JPH10511960A (no)
CN (1) CN1168097A (no)
AU (1) AU702407B2 (no)
BR (1) BR9606754A (no)
CA (1) CA2208868A1 (no)
CZ (1) CZ212497A3 (no)
HU (1) HUP9800133A3 (no)
IL (1) IL116747A (no)
NO (1) NO973242L (no)
WO (1) WO1996021442A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE532777T1 (de) 2004-09-21 2011-11-15 Marshall Edwards Inc Substituierte chromanderivate, medikamente und anwendungen in der therapie
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
JP6013349B2 (ja) 2010-11-01 2016-10-25 メイ ファーマ, インク.Mei Pharma, Inc. 癌の処置のためのイソフラボノイド化合物および方法
AU2015213484B2 (en) 2014-02-07 2015-11-05 Kazia Therapeutics Limited Functionalised benzopyran compounds and use thereof
ES2877712T3 (es) 2015-02-02 2021-11-17 Mei Pharma Inc Terapias combinadas para su uso en el tratamiento del cáncer de mama

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3822287A (en) * 1969-04-17 1974-07-02 Rexall Drug Chemical Process for preparation of substituted 3,4-(diphenyl)chromans
US4447622A (en) * 1981-09-22 1984-05-08 Council Of Scientific And Industrial Research Rafi Marg Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof
US4895715A (en) * 1988-04-14 1990-01-23 Schering Corporation Method of treating gynecomastia
US5364847A (en) * 1989-03-10 1994-11-15 Endorecherche Inhibitors of sex steroid biosynthesis and methods for their production and use
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives

Also Published As

Publication number Publication date
HUP9800133A2 (hu) 1998-12-28
CA2208868A1 (en) 1996-07-18
NO973242L (no) 1997-07-11
CN1168097A (zh) 1997-12-17
EP0809496A1 (en) 1997-12-03
WO1996021442A1 (en) 1996-07-18
CZ212497A3 (en) 1997-11-12
HUP9800133A3 (en) 1999-12-28
AU702407B2 (en) 1999-02-18
MX9705218A (es) 1997-10-31
US5919812A (en) 1999-07-06
BR9606754A (pt) 1998-01-06
IL116747A (en) 1999-11-30
IL116747A0 (en) 1996-05-14
AU4329096A (en) 1996-07-31
JPH10511960A (ja) 1998-11-17

Similar Documents

Publication Publication Date Title
FI925615A0 (fi) Stabiliserade farmaceutiska kompositioner, som innehaoller en hmg-coa-reduktas-inhibitorfoerening
NO306446B1 (no) Oralt farmasöytisk preparat omfattende tramadol med regulert frigjöringsvirkning
NO943888D0 (no) Farmasöytisk preparat
FI973828A (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
NO973243D0 (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av gynekologiske sykdommer
NO20041007L (no) Anvendelse av oksypurin-nukleosider for fremstilling av et farmasoytisk preparat
EE04681B1 (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
NO942303D0 (no) Farmasöytisk preparat, samt fremgangsmåte for fremstilling derav
NO973342D0 (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av cerebrale degenerative sykdommer
BR9404225A (pt) Formulação de substância ativa, aplicação, composições, medicamentos e processo para a preparação das formulações
NO973340D0 (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme
NO973242D0 (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti
IL116745A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
NO975680D0 (no) Oralt, farmasöytisk preparat av piperidinoalkanol-forbindelser i opplösningsform
NO973341D0 (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for vasodilatorisk behandling eller profylakse
NO903347L (no) 14,17alfa-ethano- og ethanooestratriener, fremgangsmaate forfremstilling av disse forbindelser, saavel som anvendelse av dem for fremstilling av legemidler.
FI951759A0 (fi) Menetelmä 2,2-difluoriketeenisilyyli-O,S-asetaalien ja alfa, alfa-difluori-beta-silyylioksi-1,3-dioksolaani-4-propaanihapon O,S-estereiden valmistamiseksi
NO913162L (no) Farmasoeytisk preparat for behandling av tonsillitt.
DK256689D0 (da) 1,2-dithiol-3-thion-s-oxid-forbindelser til anven delse som laegemidler
EE04155B1 (et) 2,4,4-triasendatud-1,3-dioksolaanid, nende valmistamismeetod, kasutamine, farmatseutiline kompositsioon, kombinatsioon ja produkt
IT8721540A0 (it) Composizioni farmaceutiche contenenti trapidil, loro procedimento di preparazione erelativo impiego terapeutico.
ITMI931371A1 (it) Procedimento per la preparazione dell'erdosteina
FI961717A (fi) Menetelmä oraalisten, kinoloneja sisältävien valmisteiden valmistamiseksi
NO179817C (no) Anvendelse av 4,9,11-trien-steroider for fremstilling av et farmasöytisk preparat
IT8820571A0 (it) Agente antiinfiammatorio per la terapia dell'ipertrofia prostatica, sua preparazione e relative composizioni farmaceutiche.